EcoNugenics introduces CIRCUTOL Cardiovascular Health Support

NewsGuard 100/100 Score

Just in time for Heart Health Month, EcoNugenics introduces CIRCUTOL™ Cardiovascular Health Support. EcoNugenics has once again demonstrated excellence in being at the forefront of the latest developments in natural alternative health solutions.

Circutol:

  • Promotes cardiovascular health
     
  • Supports healthy circulation
     
  • Supports healthy blood pressure
     
  • Scientifically researched formula

Unique Ingredient Provides Heart Support

The key ingredient in Circutol is Nattokinase.

Nattokinase is an enzyme derived from the Japanese superfood Natto, a popular fermented soybean dish. Volumes of laboratory and clinical studies have revealed this single enzyme's ability to support healthy blood pressure and maintain circulatory health.  This formula promotes comprehensive heart health: Two specialty botanicals Hawthorn Berry (Crataegus pinnatifida), and Chinese salvia (Salvia miltiorrhiza; two Medicinal mushrooms, Certified Organic Ganoderma lucidium, commonly known as Reishi, and Cordyceps sinensis, & completing the formula is the naturally occurring compound, L-carnitine. To purchase Circutol or to learn more, visit the EcoNugenics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Younger adults with atrial fibrillation face higher rates of heart failure and stroke